Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

550.54 +0.41 (+0.07%)
Official Closing Price Updated: 7:00 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
47 48 Next >
Beat the Dow Jones With This Unstoppable Dividend Stock
This company has been on a roll, and there is more where that came from. 
Via The Motley Fool
'Miracle' Weightloss Drugs Ozempic And Mounjaro Face Lawsuit Over Alleged Gastroparesis Side Effect
Via Benzinga
Capturing Steady Consumer Spending on Health Care with XLV
--News Direct-- 
Via News Direct
Topics ETFs Economy
Exposures Economy
Ozempic Could Have a New Multibillion-Dollar Market Opportunity. Is Novo Nordisk Stock a No-Brainer Buy?
Novo Nordisk received some good news in a recent physician survey. 
Via The Motley Fool
This Is What Whales Are Betting On Eli Lilly
Via Benzinga
Better Alzheimer's Drug Stock: Eli Lilly vs. Biogen
By 2024, their medicines will likely be competing on the market, and one might win. 
Via The Motley Fool
2 Healthcare Stocks That Could Make You Richer
Investors see the obvious potential in both companies. 
Via The Motley Fool
This Is What Whales Are Betting On Eli Lilly
Via Benzinga
Is Eli Lilly Stock Still a Top-Growth Play?
The drugmaker may be running out of steam. 
Via The Motley Fool
AI Stock Marvell And Eli Lilly Lead 5 Names Near Buy Points As S&P 500 Rallies On
Top AI stock Marvell Technology and Eli Lilly lead this watch list of five stocks near buy points as the S&P 500 bull market revs back up. 
Via Investor's Business Daily
Competition in Weight Loss Drug Space: Eli Lilly's Obesity Drug Succeeds In Two Late-Stage Studies, Shows About 26% Weight Loss
Eli Lilly And Co (NYSE: LLY) announced the results of two phase 3 tirzepatide studies in adults with obesity or overweight with weight-related comorbidities,  
Via Benzinga
7 Millionaire-Maker Healthcare Stocks to Buy Before the Window Closes
Healthcare stocks are presenting a big opportunity to long-term investors who are willing to buy and hold. 
Via InvestorPlace
Neuroinflammation A Key Indicator For Alzheimer’s, But Current Treatments Show Little Success In Reducing Or Even Increase It — Could This Rising Company Have The Answer?
--News Direct-- 
Via News Direct
Exposures Product Safety
$1000 Invested In Eli Lilly 20 Years Ago Would Be Worth This Much Today
Via Benzinga
Eli Lilly Unusual Options Activity For July 18
Via Benzinga
Is It Too Late to Buy Eli Lilly Stock?
Shares of the pharmaceutical giant are already up 36% this year. 
Via The Motley Fool
Eli Lilly vs. Novo Nordisk: What's the Better Weight-Loss Stock to Buy?
These two drug companies have seen red-hot demand for their weight-loss treatments. 
Via The Motley Fool
3 Risky Stocks to Avoid at All Costs in 2023
These are the top stocks to avoid before the stock market rally starts to lose momentum and plateau this year. 
Via InvestorPlace
Novo Nordisk's Diabetes, Weight Loss Drugs Under UK Scrutiny: Follows Suicidal Behavior Reports
The Medicines and Healthcare Products Regulatory Agency (MHRA), the U.K.'s drug regulatory authority, is reportedly scrutinizing a category of drugs used in diabetes medication and a weight loss... 
Via Benzinga
The EV Truck War Is Officially On
Telsa finally introduces the Cybertruck and Ford fights back with a price cut on the F-150 Lightning. 
Via The Motley Fool
All Eyes On Biogen's Alzheimer's Drug, A Big Potential Payday, Ahead Of Earnings
Analysts expect Biogen to report a a decline in both profits and sales in Q2. 
Via Investor's Business Daily
Russia Is Seizing European Company Assets — What US Businesses Are Still At Risk?
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
The 3 Most Undervalued Pharma Stocks to Buy Now: July 2023
Trading below a 15 forward price-to-earnings, these undervalued pharma stocks offer opportunities in an overbought market. 
Via InvestorPlace
Eli Lilly's Solid Portfolio Alzheimer's & Diabetes Drugs To Aid Sales Growth: Analyst
Truist Securities analyst Robyn Karnauskas reiterated a Buy rating on Eli Lilly And Company (NYSE: LLY),  
Via Benzinga
2 Healthcare Stocks That Could Join the $1 Trillion Club by 2033
These are buy-and-forget type investments that you can hang on to for years. 
Via The Motley Fool
My Take: 4 Strong Growth Stocks to Buy This Week
The key to growth stocks is finding ones with significant tailwinds. 
Via The Motley Fool
3 Biotech Stocks for Getting Rich in 2023
These 3 biotech stocks have seen stable or growing revenue this year. This makes them companies to keep on your watchlist. 
Via InvestorPlace
Why Alnylam Pharmaceuticals Topped the Market Today
Monday was a good day for biotechs fighting the good fight against a common degenerative brain disorder. 
Via The Motley Fool
Eli Lilly's Alzheimer's Drug Candidate Slows Progression By 60% In Mildly Impaired Patients
Eli Lilly And Co (NYSE: LLY) presented full results from the Phase 3 TRAILBLAZER-ALZ 2 study showing that donanemab significantly slowed cognitive and functional decline in people with early  
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
47 48 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.